Rtw Investments, LP Merus N.V. Transaction History
Rtw Investments, LP
- $6.1 Billion
- Q1 2025
A detailed history of Rtw Investments, LP transactions in Merus N.V. stock. As of the latest transaction made, Rtw Investments, LP holds 4,169,393 shares of MRUS stock, worth $267 Million. This represents 2.88% of its overall portfolio holdings.
Number of Shares
4,169,393
Previous 4,169,393
-0.0%
Holding current value
$267 Million
Previous $175 Million
0.1%
% of portfolio
2.88%
Previous 2.86%
Shares
7 transactions
Others Institutions Holding MRUS
# of Institutions
194Shares Held
62.4MCall Options Held
355KPut Options Held
96.4K-
Wellington Management Group LLP Boston, MA4.72MShares$302 Million0.04% of portfolio
-
Commodore Capital LP New York, NY4.47MShares$286 Million18.43% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.37MShares$216 Million7.27% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.17MShares$203 Million3.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$192 Million2.04% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.94B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...